Skip to main content
Log in

Interstitial brachytherapy and hyperthermia for malignant gliomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Interstitial brachytherapy has well-known radiobiological and radiophysical advantages that has made delivery of high doses of radiation to malignant brain tumors a possibility [1]. Over the past 10 years a great deal of clinical information attesting to the usefulness of brachytherapy in the treatment of malignant gliomas has been accrued.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bernstein M, Gutin PH: Interstitial irradiation of brain tumors: a review. Neurosurgery 9: 741, 1981

    PubMed  Google Scholar 

  2. Leibel SA, Gutin PH, Wara WMet al.: Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17: 1129, 1989

    PubMed  Google Scholar 

  3. Weaver K, Smith V, Lewis JDet al.: A CT-based computerized treatment planning system for I-125 stereotactic brain implants. Int J Radiat Oncol Biol Phys 18: 445, 1990

    PubMed  Google Scholar 

  4. Gutin PH, Dormandy RH Jr: A coaxial catheter system for afterloading radioactive sources for the interstitial irradiation of brain tumors. Technical note. J Neurosurg 56: 734, 1982

    PubMed  Google Scholar 

  5. Satoh T, Stauffer PR, Fike JR: Thermal distribution studies of helical coil microwave antennas for interstitial hyperthermia. Int J Radiat Oncol Biol Phys 15: 1209, 1988

    PubMed  Google Scholar 

  6. Scharfen CO, Sneed PK, Wara WMet al.: High activity iodine-125 implant for gliomas. Int J Radiat Oncol Biol Phys 24:1992 (in press)

  7. Gutin PH, Leibel SA, Wara WMet al.: Recurrent malignant gliomas: survival following interstitial brachytherapy with high-activity iodine-125 sources. J Neurosurg 67: 864, 1987

    PubMed  Google Scholar 

  8. Sneed PK, Gutin PH, Stuaffer PRet al.: Thermoradiotherapy of recurrent malignant brain tumors. Int J Radiat Oncol Biol Phys 23: 853, 1992

    PubMed  Google Scholar 

  9. Gutin PH, Prados MD, Phillips TLet al.: External irradiation followed by an interstitial high activity iodine-125 implant ‘boost’ in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 21: 601, 1991

    PubMed  Google Scholar 

  10. Walker MD, Alexander E Jr, Hunt WEet al.: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49: 333, 1978

    PubMed  Google Scholar 

  11. Loeffler JS, Alexander E, Wen PYet al.: Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. J Natl Cancer Inst 82: 1918, 1990

    PubMed  Google Scholar 

  12. Bernstein M, Laperriere N, Leung Pet al.: Interstitial brachytherapy for malignant brain tumors: preliminary results. Neurosurgery 26: 371, 1990

    PubMed  Google Scholar 

  13. Chun M, McKeough P, Wu Aet al.: Interstitial iridium-192 implantation for malignant brain tumors. Br J Radiol 62: 158, 1989

    PubMed  Google Scholar 

  14. Kumar PP, Good RR, Jones EOet al.: Survival of patients with glioblastoma multiforme treated by intraoperative high-activity cobalt 60 endocurietherapy. Cancer 64: 1409, 1989

    PubMed  Google Scholar 

  15. Mundinger F, Ostertag CB, Birg Wet al.: Stereotactic treatment of brain lesions: biopsy, interstitial radiotherapy (iridium-192 and iodine-125) and drainage procedures. Appl Neurophysiol 43: 1948, 1980

    Google Scholar 

  16. Patchell RA, Maruyama Y, Tibbs PAet al.: Neutron interstitial brachytherapy for malignant gliomas. A pilot study. J Neurosurg 68: 67, 1988

    PubMed  Google Scholar 

  17. Selker R, Eddy M, Arena V: Pittsburgh brachytherapy experience. Second Symposium on Stereotactic Treatment of Brain Tumors, 1991

  18. Kornblith P, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68: 1, 1988

    PubMed  Google Scholar 

  19. Nelson D, Nelson J, Davis Det al: Survival and prognosis of patients with astrocytoma with atypical or anaplastic features. J Neurooncol 3: 99, 1985

    PubMed  Google Scholar 

  20. Levin VA, Silver P, Hannigan Jet al.: Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321, 1990

    PubMed  Google Scholar 

  21. Florell RC, MacDonald DR, Irish WDet al: Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76: 179, 1992

    PubMed  Google Scholar 

  22. Agbi CB, Bernstein M, Laperriere Net al: Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants. Int J Radiat Oncol Biol Phys 23: 321, 1992

    PubMed  Google Scholar 

  23. Prados MD, Gutin PH, Phillips TLet al.: Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 23: 3, 1992

    PubMed  Google Scholar 

  24. Loeffler JS, Alexander E, Hochberg FHet al.: Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 19: 1455, 1990

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gutin, P.H., Shrieve, D.C., Larson, D.A. et al. Interstitial brachytherapy and hyperthermia for malignant gliomas. J Neuro-Oncol 17, 161–166 (1993). https://doi.org/10.1007/BF01050219

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01050219

Key words

Navigation